LMR Partners LLP

Q1 2023 13F-HR Holdings

Location
London, X0
Holdings as of
3/31/2023
Date filed
5/15/2023
Form type
13F-HR
Num holdings
1,004
Total value ($000)
$6,454,091
Net value change ($000)
+725,481 (12.7%)
New positions
211
Sold out positions
267
Turnover %
56.3%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 2/14/2023 Next filing: 8/14/2023 SEC filing

Snapshot: Change Analysis

Compared to Q4 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Horizon Therapeutics Public Ltd Co 74,024 530.1%
GLD 59,626 130.7%
NVDA 58,236 633.1%
FHN 56,281 274.1%
LPLA 45,671 606.4%
WFC 43,245 4576.2%
AZN 42,675 NEW
BLK 40,885 591.9%
MSFT 39,793 NEW
BP 39,781 NEW
Top Reduces (Value $000, Stocks/ETFs)
TSM -92,489 -71.0%
BK -59,962 -100.0%
FXI -42,450 -100.0%
LUNR -29,000 -100.0%
ADBE -28,376 -100.0%
OXY -27,535 -87.7%
FLEX -25,936 -89.5%
FE -25,163 -100.0%
TEAM -23,957 -100.0%
CRUS -22,344 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 946,657 (14.7% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type